UK invests to be 'world leader in saving lives through AI and genomics'

8 August 2019

Pharma and other health companies are buying big into the artificial intelligence (AI) space, and the UK’s Health Secretary has now given this technology a major vote of confidence too.

Matt Hancock has announced a £250 million ($304 million) investment in AI, saying that the health tech revolution could “transform patient experience “ within the National Health Service (NHS).

The project will be led by the National AI Lab, which will bring together the industry’s best academics, specialists and tech companies to work on some of the biggest challenges in health and care, including earlier cancer detection, new dementia treatments and more personalized care.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK